Chemical Compound
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxido-pyridin-1-ium-2-carboxamide; Sorafenib N-Oxide
CAS Registry Number
583840-03-3
Primary record
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxido-pyridin-1-ium-2-carboxamide; Sorafenib N-Oxide
- 库存
- 3,391 克
- 纯度
- 99.6 %
- CAS
- 583840-03-3
化合物标识与属性
- CAS
- 583840-03-3
- PubChem CID
- 9826472
- SMILES
- CNC(=O)C1=[N+](C=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)[O-]
- Canonical SMILES
- CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)cc[n+]1[O-]
名称与同义词
- Sorafenib N-Oxide
- Srf-nox
- Sorafenib N oxide
- Sorafenib-N-oxide
- 583840-03-3
- Sorafenib metabolite M2
- Sorafenib Impurity 22
- 5XYK65KIGD
- RefChem:184377
- Sorafenib major metabolite
- Sorafenib Tosylate N-Oxide
- SCHEMBL548256
- DTXSID60431376
- orb1693535
- BAY-673472
- SCHEMBL29733289
- CTK8E8479
- DTXCID10382208
- BQAZCCVUZDIZDC-UHFFFAOYSA-N
- ZINC3817152
- BAY-67-3472
- J2.910.287B
- CID9826472
- FS27857
- CID 9826472
- lithium,3,4-dimethyl-2H-thiophen-2-ide
- RT-015755
- CS-0132815
- FT-0674634
- 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-2-(methylcarbamoyl)pyridine 1-oxide
- G92139
- 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxidopyridin-1-ium-2-carboxamide
- Q27263023
- 1-[4-[(4-nitrophenyl)methylidene]pyridin-1-yl]ethanone
- 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide
- 2-Pyridinecarboxamide, 4-(4((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)N-methyl-,1-oxide
- 4-(4-(((4-Chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-methylpyridine-2-carboxamide 1-oxide
- ((4S,5S)-(-)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl]-dicyclohexylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (S,S)-[COD]Ir[c
- 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxido-pyridin-1-ium-2-carboxamide; Sorafenib N-Oxide
- 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate
- 4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL}AMINO)PHENOXY]-2-(METHYLCARBAMOYL)PYRIDIN-1-IUM-1-OLATE
- 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methyl-1-oxo-1lambda~5~-pyridine-2-carboxamide
- 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-2-(methylaminocarbonyl)pyridine 1-oxide
- 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-2-(methylcarbamoyl)pyridine 1-oxide
- 583844-38-6
- 58385-52-7
- 583855-46-3